Astrana Health (ASTH) Common Equity (2011 - 2026)

Astrana Health (ASTH) has 16 years of Common Equity data on file, last reported at $815.2 million in Q1 2026.

• Quarterly Common Equity rose 8.63% year-over-year to $815.2 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $815.2 million (up 8.63% YoY) and the FY2025 annual result came in at $779.3 million, up 8.73% from the prior year.
• Common Equity advanced to $815.2 million in Q1 2026 per ASTH's latest filing, from $779.3 million in the prior quarter.
• The five-year high for Common Equity was $815.2 million in Q1 2026, with the low at $472.6 million in Q1 2022.
• Average Common Equity over 5 years is $647.6 million, with a median of $658.0 million recorded in 2024.
• Year-over-year, Common Equity jumped 36.19% in 2022 and increased 8.63% in 2026.
• Astrana Health's Common Equity stood at $544.3 million in 2022, then advanced by 13.29% to $616.7 million in 2023, then grew by 16.23% to $716.7 million in 2024, then gained by 8.73% to $779.3 million in 2025, then grew by 4.61% to $815.2 million in 2026.
• Business Quant data shows ASTH's Common Equity at $815.2 million in Q1 2026, $779.3 million in Q4 2025, and $789.1 million in Q3 2025.